XISTA × BioInnovation Institute (BII) - Connecting Research, Infrastructure, and Early Capital
Founded by the Novo Nordisk Foundation, BII operates as a life science incubator and commercialization platform in Copenhagen, focused on bringing research from academia into viable companies. It provides early-stage funding, laboratory infrastructure, and hands-on venture support, helping founders move from scientific discovery toward investment-ready businesses.
What distinguishes BII is its integrated model. Startups are not only funded, but embedded in an environment that combines scientific expertise, business development, and access to international networks. Through programs such as Venture Lab and Bio Studio, teams receive structured support — from proof of concept to company formation — often before traditional investors would engage.
This approach reflects a broader European challenge: world-class research exists, but often lacks the infrastructure to translate into companies at scale. BII’s platform is built to bridge exactly this gap, supporting more than 100 startups and helping them attract significant follow-on funding.
The partnership with XISTA extends this model beyond a single ecosystem. By combining a €500,000 investment from XISTA with participation in BII’s Venture Lab and access to the ISTA innovation environment, founders gain both structured incubation and early venture backing.
Rather than a standalone program, the collaboration connects two complementary systems — Copenhagen’s life science commercialization engine and XISTA’s deep-tech investment platform. The shared objective is clear: enable science founders to move faster from research to company, with the infrastructure, capital, and guidance required at each step.
Links:
- BII Venture Lab / programs
- XISTA × BII collaboration page
